{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:29:12Z","timestamp":1761895752116},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T00:00:00Z","timestamp":1384300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s10067-013-2423-z","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T04:22:36Z","timestamp":1384230156000},"page":"725-731","source":"Crossref","is-referenced-by-count":11,"title":["Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature"],"prefix":"10.1007","volume":"33","author":[{"given":"Agnieszka","family":"Jurecka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Zakharova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Malinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Voskoboeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Tylki-Szyma\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,13]]},"reference":[{"key":"2423_CR1","first-page":"3421","volume-title":"The metabolic and molecular basis of inherited disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 3421\u20133452"},{"key":"2423_CR2","author":"V Opoka-Winiarska","year":"2013","unstructured":"Opoka-Winiarska V, Jurecka A, Emeryk A, Tylki-Szymanska A (2013) Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation. Osteoarthr Cartilage. doi: 10.1016\/j.joca.2013.08.001","journal-title":"Osteoarthr Cartilage"},{"issue":"1","key":"2423_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-5-5","volume":"5","author":"V Valayannopoulos","year":"2010","unstructured":"Valayannopoulos V, Nicely H, Harmatz P, Turbeville S (2010) Mucopolysaccharidosis VI. Orphanet J Rare Dis 5(1):5. doi: 10.1186\/1750-1172-5-5","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2423_CR4","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1651-2227.2008.00965.x","volume":"97","author":"G Malm","year":"2008","unstructured":"Malm G, Lund AM, Mansson JE, Heiberg A (2008) Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence. Acta Paediatr 97(11):1577\u20131581. doi: 10.1111\/j.1651-2227.2008.00965.x","journal-title":"Acta Paediatr"},{"issue":"6","key":"2423_CR5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","volume":"28","author":"F Baehner","year":"2005","unstructured":"Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, Kohlschutter A, Kampmann C, Beck M (2005) Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 28(6):1011\u20131017. doi: 10.1007\/s10545-005-0112-z","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"2423_CR6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ymgme.2011.11.003","volume":"105","author":"A Jurecka","year":"2012","unstructured":"Jurecka A, Piotrowska E, Cimbalistiene L, Gusina N, Sobczynska A, Czartoryska B, Czerska K, Ounap K, Wegrzyn G, Tylki-Szymanska A (2012) Molecular analysis of mucopolysaccharidosis type VI in Poland, Belarus, Lithuania and Estonia. Mol Genet Metab 105(2):237\u2013243. doi: 10.1016\/j.ymgme.2011.11.003","journal-title":"Mol Genet Metab"},{"issue":"4","key":"2423_CR7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ymgme.2011.08.024","volume":"104","author":"A Jurecka","year":"2011","unstructured":"Jurecka A, Golda A, Opoka-Winiarska V, Piotrowska E, Tylki-Szymanska A (2011) Mucopolysaccharidosis type VI (Maroteaux\u2013Lamy syndrome) with a predominantly cardiac phenotype. Mol Genet Metab 104(4):695\u2013699. doi: 10.1016\/j.ymgme.2011.08.024","journal-title":"Mol Genet Metab"},{"issue":"6","key":"2423_CR8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/ajmg.a.35905","volume":"161","author":"A Jurecka","year":"2013","unstructured":"Jurecka A, Zakharova E, Cimbalistiene L, Gusina N, Kulpanovich A, Golda A, Opoka-Winiarska V, Piotrowska E, Voskoboeva E, Tylki-Szyma\u0144ska A (2013) Mucopolysaccharidosis type VI: a predominantly cardiac phenotype associated with a homozygosity for p.R152W mutation in the ARSB gene. Am J Med Genet 161(6):1291\u20131299","journal-title":"Am J Med Genet"},{"issue":"3","key":"2423_CR9","first-page":"454","volume":"54","author":"D Isbrandt","year":"1994","unstructured":"Isbrandt D, Arlt G, Brooks DA, Hopwood JJ, von Figura K, Peters C (1994) Mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes. Am J Hum Genet 54(3):454\u2013463","journal-title":"Am J Hum Genet"},{"issue":"9","key":"2423_CR10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/humu.20534","volume":"28","author":"L Karageorgos","year":"2007","unstructured":"Karageorgos L, Brooks DA, Pollard A, Melville EL, Hein LK, Clements PR, Ketteridge D, Swiedler SJ, Beck M, Giugliani R, Harmatz P, Wraith JE, Guffon N, Le\u00e3o Teles E, S\u00e1 Miranda MC, Hopwood JJ (2007) Mutational analysis of 105 mucopolysaccharidosis type VI patients. Hum Mutat 28(9):897\u2013903. doi: 10.1002\/humu.20534","journal-title":"Hum Mutat"},{"issue":"3","key":"2423_CR11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ymgme.2011.03.024","volume":"103","author":"I Gottwald","year":"2011","unstructured":"Gottwald I, Hughes J, Stewart F, Tylee K, Church H, Jones SA (2011) Attenuated mucopolysaccharidosis type VI (Maroteaux\u2013Lamy syndrome) due to homozygosity for the p.Y210C mutation in the ARSB gene. Mol Genet Metab 103(3):300\u2013302. doi: 10.1016\/j.ymgme.2011.03.024","journal-title":"Mol Genet Metab"},{"key":"2423_CR12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01652494","volume":"83","author":"M Nonne","year":"1925","unstructured":"Nonne M (1925) Familiares Vorkommen (3 Geschwister) einer Kombination von imperfekter Chondrodystrophie mit imperfektem Myxoedema infantilis. Dtsch Z Nervenheilkd 83:263\u2013273","journal-title":"Dtsch Z Nervenheilkd"},{"issue":"4","key":"2423_CR13","first-page":"376","volume":"21","author":"S Rampini","year":"1966","unstructured":"Rampini S, Maroteaux P (1966) An uncommon phenotype of Hurler\u2019s syndrome. Helv Paediatr Acta 21(4):376\u2013386","journal-title":"Helv Paediatr Acta"},{"issue":"4","key":"2423_CR14","first-page":"337","volume":"25","author":"JW Spranger","year":"1970","unstructured":"Spranger JW, Koch F, McKusick VA, Natzschka J, Wiedemann HR, Zellweger H (1970) Mucopolysaccharidosis VI (Maroteaux\u2013Lamy\u2019s disease). Helv Paediatr Acta 25(4):337\u2013362","journal-title":"Helv Paediatr Acta"},{"key":"2423_CR15","volume-title":"Heritable disorders of connective tissue","author":"VA McKusick","year":"1972","unstructured":"McKusick VA (1972) Heritable disorders of connective tissue, 4th edn. Mosby, St. Louis","edition":"4"},{"issue":"2","key":"2423_CR16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.a.30579","volume":"134A","author":"SJ Swiedler","year":"2005","unstructured":"Swiedler SJ, Beck M, Bajbouj M, Giugliani R, Schwartz I, Harmatz P, Wraith JE, Roberts J, Ketteridge D, Hopwood JJ, Guffon N, Sa Miranda MC, Teles EL, Berger KI, Piscia-Nichols C (2005) Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome). Am J Med Genet A 134A(2):144\u2013150. doi: 10.1002\/ajmg.a.30579","journal-title":"Am J Med Genet A"},{"issue":"6","key":"2423_CR17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10545-005-0020-2","volume":"28","author":"MFG Petry","year":"2005","unstructured":"Petry MFG, Nonemacher K, Sebben JC, Schwartz IVD, Azevedo ACM, Burin MG, Rezende AR, Kim CA, Giugliani R, Leistner-Segal S (2005) Mucopolysaccharidosis type VI: identification of novel mutations on the arylsulphatase B gene in South American patients. J Inherit Metab Dis 28(6):1027\u20131034. doi: 10.1007\/s10545-005-0020-2","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2423_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2012.05.115","volume":"167","author":"A Golda","year":"2013","unstructured":"Golda A, Jurecka A, Opoka-Winiarska V, Tylki-Szymanska A (2013) Mucopolysaccharidosis type VI: a cardiologist\u2019s guide to diagnosis and treatment. Int J Cardiol 167(1):1\u201310. doi: 10.1016\/j.ijcard.2012.05.115","journal-title":"Int J Cardiol"},{"issue":"1","key":"2423_CR19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2011.06.097","volume":"158","author":"A Golda","year":"2011","unstructured":"Golda A, Jurecka A, Tylki-Szymanska A (2011) Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux\u2013Lamy syndrome). Int J Cardiol 158(1):6\u201311. doi: 10.1016\/j.ijcard.2011.06.097","journal-title":"Int J Cardiol"},{"issue":"2","key":"2423_CR20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/S1047951109003576","volume":"19","author":"V Fesslova","year":"2009","unstructured":"Fesslova V, Corti P, Sersale G, Rovelli A, Russo P, Mannarino S, Butera G, Parini R (2009) The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses. Cardiol Young 19(2):170\u2013178. doi: 10.1017\/S1047951109003576","journal-title":"Cardiol Young"},{"issue":"3","key":"2423_CR21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.amjcard.2006.02.047","volume":"98","author":"E Braunlin","year":"2006","unstructured":"Braunlin E, Berry J, Whitley C (2006) Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am J Cardiol 98(3):416\u2013418. doi: 10.1016\/j.amjcard.2006.02.047","journal-title":"Am J Cardiol"},{"issue":"1","key":"2423_CR22","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1542\/peds.2006-2156","volume":"120","author":"JE Wraith","year":"2007","unstructured":"Wraith JE, Beck M, Lane R, van der Ploeg A, Shapiro E, Xue Y, Kakkis ED, Guffon N (2007) Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-l-iduronidase (laronidase). Pediatrics 120(1):e37\u2013e46. doi: 10.1542\/peds.2006-2156","journal-title":"Pediatrics"},{"issue":"1","key":"2423_CR23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2009.08.006","volume":"99","author":"T Okuyama","year":"2010","unstructured":"Okuyama T, Tanaka A, Suzuki Y, Ida H, Tanaka T, Cox GF, Eto Y, Orii T (2010) Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (mucopolysaccharidosis II, MPS II). Mol Genet Metab 99(1):18\u201325. doi: 10.1016\/j.ymgme.2009.08.006","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2423_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-006-0280-4","volume":"121","author":"M Beck","year":"2007","unstructured":"Beck M (2007) New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy. Hum Genet 121(1):1\u201322. doi: 10.1007\/s00439-006-0280-4","journal-title":"Hum Genet"},{"key":"2423_CR25","doi-asserted-by":"crossref","unstructured":"Pilz H, von Figura K, Goebel HH (1979) Deficiency of arylsulfatase B in 2 brothers aged 40 and 38 years (Maroteaux-Lamy syndrome, type B). Ann Neurol 6(4):315\u2013325. doi: 10.1002\/ana.410060405","DOI":"10.1002\/ana.410060405"},{"key":"2423_CR26","doi-asserted-by":"crossref","unstructured":"Paterson DE, Harper G, Weston HJ, Mattingley J (1982) Maroteaux-Lamy syndrome, mild form--MPS vi b. Br J Radiol 55(659):805\u2013812","DOI":"10.1259\/0007-1285-55-659-805"},{"key":"2423_CR27","doi-asserted-by":"crossref","unstructured":"Tonnesen T, Gregersen HN, Guttler F (1991) Normal MPS excretion, but dermatan sulphaturia, combined with a mild Maroteaux-Lamy phenotype. J Med Genet 28(7):499\u2013501","DOI":"10.1136\/jmg.28.7.499"},{"key":"2423_CR28","unstructured":"Litjens T, Brooks DA, Peters C, Gibson GJ, Hopwood JJ (1996) Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients. Am J Hum Genet 58(6):1127\u20131134"},{"key":"2423_CR29","doi-asserted-by":"crossref","unstructured":"Brooks DA, Gibson GJ, Karageorgos L, Hein LK, Robertson EF, Hopwood JJ (2005) An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum. Mol Genet Metab 85(3):236\u2013238. doi: 10.1016\/j.ymgme.2005.02.008","DOI":"10.1016\/j.ymgme.2005.02.008"},{"key":"2423_CR30","doi-asserted-by":"crossref","unstructured":"Scarpa M, Buffone E, La Marca P, Campello M, Rampazzo A (2010) Difficulties in diagnosing slowly progressive mucopolysaccharidosis VI: a case series. Journal of pediatric rehabilitation medicine 3:71\u201375","DOI":"10.3233\/PRM-2010-0104"},{"key":"2423_CR31","doi-asserted-by":"crossref","unstructured":"Th\u00fcmler A, Miebach E, Lampe C, Pitz S, Kamin W, Kampmann C, Link B, Mengel E (2012) Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series. J Inherit Metab Dis 35(6):1071\u20131079. doi: 10.1007\/s10545-012-9474-1","DOI":"10.1007\/s10545-012-9474-1"},{"key":"2423_CR32","doi-asserted-by":"crossref","unstructured":"Voskoboeva E, Isbrandt D, von Figura K, Krasnopolskaya X, Peters C (1994) Four novel mutant alleles of the arylsulfatase B gene in two patients with intermediate form of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Hum Genet 93(3):259-264","DOI":"10.1007\/BF00212019"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2423-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2423-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2423-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T19:11:20Z","timestamp":1596827480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2423-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,13]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["2423"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2423-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,13]]}}}